Clinical Trial Results:
Safety and efficacy of S 33138 versus risperidone in schizophrenic patients with predominant positive symptoms:
A pilot phase IIa, international, multicentre, randomised, double-blind, parallel-group, controlled study.
Summary
|
|
EudraCT number |
2005-000016-27 |
Trial protocol |
AT HU DE IT ES |
Global completion date |
17 Oct 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Dec 2016
|
First version publication date |
10 Dec 2016
|
Other versions |
|
Summary report(s) |
Synopsis dated on 25-February-2008 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.